Agbonesa, Mark Jay T.
HRN: 21-32-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2022
CEFTRIAXONE 1G (VIAL)
05/11/2022
05/17/2022
IV DRIP
700mg
OD
ALL
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes